Non-lipid-related effects of statins

Stefano Bellosta, Nicola Ferri, Franco Bernini, Rodolfo Paoletti, Alberto Corsini

Research output: Contribution to journalArticle

Abstract

The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) on coronary events have generally been attributed to their hypocholesterolaemic properties. However, as mevalonate and other intermediates of cholesterol synthesis (isoprenoids) are necessary for cell proliferation and other important cell functions, effects other than cholesterol reduction may explain the pharmacological properties of statins. In the present review, we discuss the current knowledge on the nonlipid-related effects of statins, with a special emphasis on their potential benefits in different diseases, such as atherosclerosis and cancer. The mechanism(s) responsible for their favourable properties are also reviewed.

Original languageEnglish
Pages (from-to)164-176
Number of pages13
JournalAnnals of Medicine
Volume32
Issue number3
Publication statusPublished - Apr 2000

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cholesterol
Mevalonic Acid
Terpenes
Atherosclerosis
Oxidoreductases
Cell Proliferation
Pharmacology
Neoplasms

Keywords

  • Arterial smooth muscle cell proliferation
  • Atherosclerosis
  • Cancer
  • Cholesterol accumulation
  • Endothelial function
  • Inflammation
  • Macrophages
  • Migration
  • Statins
  • Thrombosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bellosta, S., Ferri, N., Bernini, F., Paoletti, R., & Corsini, A. (2000). Non-lipid-related effects of statins. Annals of Medicine, 32(3), 164-176.

Non-lipid-related effects of statins. / Bellosta, Stefano; Ferri, Nicola; Bernini, Franco; Paoletti, Rodolfo; Corsini, Alberto.

In: Annals of Medicine, Vol. 32, No. 3, 04.2000, p. 164-176.

Research output: Contribution to journalArticle

Bellosta, S, Ferri, N, Bernini, F, Paoletti, R & Corsini, A 2000, 'Non-lipid-related effects of statins', Annals of Medicine, vol. 32, no. 3, pp. 164-176.
Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Non-lipid-related effects of statins. Annals of Medicine. 2000 Apr;32(3):164-176.
Bellosta, Stefano ; Ferri, Nicola ; Bernini, Franco ; Paoletti, Rodolfo ; Corsini, Alberto. / Non-lipid-related effects of statins. In: Annals of Medicine. 2000 ; Vol. 32, No. 3. pp. 164-176.
@article{44ed832bde7945749faec94eb1aa57f2,
title = "Non-lipid-related effects of statins",
abstract = "The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) on coronary events have generally been attributed to their hypocholesterolaemic properties. However, as mevalonate and other intermediates of cholesterol synthesis (isoprenoids) are necessary for cell proliferation and other important cell functions, effects other than cholesterol reduction may explain the pharmacological properties of statins. In the present review, we discuss the current knowledge on the nonlipid-related effects of statins, with a special emphasis on their potential benefits in different diseases, such as atherosclerosis and cancer. The mechanism(s) responsible for their favourable properties are also reviewed.",
keywords = "Arterial smooth muscle cell proliferation, Atherosclerosis, Cancer, Cholesterol accumulation, Endothelial function, Inflammation, Macrophages, Migration, Statins, Thrombosis",
author = "Stefano Bellosta and Nicola Ferri and Franco Bernini and Rodolfo Paoletti and Alberto Corsini",
year = "2000",
month = "4",
language = "English",
volume = "32",
pages = "164--176",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Non-lipid-related effects of statins

AU - Bellosta, Stefano

AU - Ferri, Nicola

AU - Bernini, Franco

AU - Paoletti, Rodolfo

AU - Corsini, Alberto

PY - 2000/4

Y1 - 2000/4

N2 - The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) on coronary events have generally been attributed to their hypocholesterolaemic properties. However, as mevalonate and other intermediates of cholesterol synthesis (isoprenoids) are necessary for cell proliferation and other important cell functions, effects other than cholesterol reduction may explain the pharmacological properties of statins. In the present review, we discuss the current knowledge on the nonlipid-related effects of statins, with a special emphasis on their potential benefits in different diseases, such as atherosclerosis and cancer. The mechanism(s) responsible for their favourable properties are also reviewed.

AB - The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) on coronary events have generally been attributed to their hypocholesterolaemic properties. However, as mevalonate and other intermediates of cholesterol synthesis (isoprenoids) are necessary for cell proliferation and other important cell functions, effects other than cholesterol reduction may explain the pharmacological properties of statins. In the present review, we discuss the current knowledge on the nonlipid-related effects of statins, with a special emphasis on their potential benefits in different diseases, such as atherosclerosis and cancer. The mechanism(s) responsible for their favourable properties are also reviewed.

KW - Arterial smooth muscle cell proliferation

KW - Atherosclerosis

KW - Cancer

KW - Cholesterol accumulation

KW - Endothelial function

KW - Inflammation

KW - Macrophages

KW - Migration

KW - Statins

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0034053890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034053890&partnerID=8YFLogxK

M3 - Article

C2 - 10821323

AN - SCOPUS:0034053890

VL - 32

SP - 164

EP - 176

JO - Annals of Medicine

JF - Annals of Medicine

SN - 0785-3890

IS - 3

ER -